High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?

I. F. Khouri; M. J. Keating

doi:10.1023/A:1008259428364

High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?

I. F. Khouri, M. J. Keating

Stem Cell Transplantation

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	131-132
Number of pages	2
Journal	Annals of Oncology
Volume	9
Issue number	2
DOIs	https://doi.org/10.1023/A:1008259428364
State	Published - 1998

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1023/A:1008259428364

Cite this

@article{411c5b39363349b389d7e369929b671f,

title = "High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?",

author = "Khouri, {I. F.} and Keating, {M. J.}",

year = "1998",

doi = "10.1023/A:1008259428364",

language = "English (US)",

volume = "9",

pages = "131--132",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - High-dose chemotherapy for chronic lymphocytic leukemia

T2 - Eligibility, timing, and benefit?

AU - Khouri, I. F.

AU - Keating, M. J.

PY - 1998

Y1 - 1998

UR - http://www.scopus.com/inward/record.url?scp=0031952452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031952452&partnerID=8YFLogxK

U2 - 10.1023/A:1008259428364

DO - 10.1023/A:1008259428364

M3 - Comment/debate

C2 - 9553656

AN - SCOPUS:0031952452

SN - 0923-7534

VL - 9

SP - 131

EP - 132

JO - Annals of Oncology

JF - Annals of Oncology

IS - 2

ER -

High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this